Literature DB >> 3010804

Molecular mechanisms of platelet aggregation.

L Leung, R Nachman.   

Abstract

Recent studies suggest that platelet stimulation leads to the induction of specific fibrinogen receptors, which have been identified as the platelet membrane glycoprotein IIb-IIIa complex. The binding of fibrinogen initiates the reversible primary phase of aggregation. With a strong stimulus, thrombospondin is released from the platelet alpha-granules. By interacting with fibrinogen, thrombospondin serves to stabilize the platelet aggregates, which leads to a secondary irreversible phase of aggregation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3010804     DOI: 10.1146/annurev.me.37.020186.001143

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  16 in total

Review 1.  Antiplatelet therapy in interventional cardiology: I. Newer oral antiplatelet agents.

Authors:  F H Jafary; C D Kimmelstiel
Journal:  J Thromb Thrombolysis       Date:  2000-02       Impact factor: 2.300

2.  Exogenous fibronectin modifies the aggregation of collagen-stimulated human platelets.

Authors:  A R Eynard; M E Pasqualini; R A Rovasio
Journal:  Experientia       Date:  1990-07-15

3.  Changes in membrane glycoproteins of circulating platelets after coronary stent implantation.

Authors:  M Gawaz; F J Neumann; I Ott; A May; S Rüdiger; A Schömig
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

4.  Platelet response to aggregated C-reactive protein: fibrinogen-dependent and independent signals.

Authors:  B A Fiedel
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

5.  ADAP is required for normal alphaIIbbeta3 activation by VWF/GP Ib-IX-V and other agonists.

Authors:  Ana Kasirer-Friede; Barry Moran; Jennifer Nagrampa-Orje; Ken Swanson; Zaverio M Ruggeri; Burkhart Schraven; Benjamin G Neel; Gary Koretzky; Sanford J Shattil
Journal:  Blood       Date:  2006-09-26       Impact factor: 22.113

6.  Plasma kallikrein enhances platelet aggregation response by subthreshold doses of ADP.

Authors:  Tatiana F Ottaiano; Sheila S Andrade; Cleide de Oliveira; Mariana C C Silva; Marcus V Buri; Maria A Juliano; Manoel J B C Girão; Misako U Sampaio; Alvin H Schmaier; Alexander Wlodawer; Francisco H A Maffei; Maria Luiza V Oliva
Journal:  Biochimie       Date:  2017-01-20       Impact factor: 4.079

7.  Adenosine diphosphate-induced aggregation of human platelets in flow through tubes. II. Effect of shear rate, donor sex, and ADP concentration.

Authors:  D N Bell; S Spain; H L Goldsmith
Journal:  Biophys J       Date:  1989-11       Impact factor: 4.033

8.  Thrombin-induced conversion of fibrinogen to fibrin results in rapid platelet trapping which is not dependent on platelet activation or GPIb.

Authors:  Gavin E Jarvis; Ben T Atkinson; Jon Frampton; Steve P Watson
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

9.  Chemically modified heparins inhibit fibrinogen-bridged indirect adhesion between tumor cells and platelets.

Authors:  Sheng Zheng; Yan Liu; Yang Jiao; Min Wei; Xianlu Zeng
Journal:  Oncol Lett       Date:  2011-12-02       Impact factor: 2.967

10.  Severity of multiple organ failure (MOF) but not of sepsis correlates with irreversible platelet degranulation.

Authors:  M Gawaz; S Fateh-Moghadam; G Pilz; H J Gurland; K Werdan
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.